Fluoxetine pharmacokinetics and tissue distribution suggest a possible role in reducing SARS-CoV-2 titers
View ORCID ProfileAndy R. Eugene
doi: https://doi.org/10.1101/2020.12.17.20248442
Andy R. Eugene
1Independent Neurophysiology Laboratory, Department of Psychiatry, Medical University of Lublin, Lublin Voivodship, Poland
2Institute for the Study of Child Development, Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA
MD, PhDArticle usage
Posted December 19, 2020.
Fluoxetine pharmacokinetics and tissue distribution suggest a possible role in reducing SARS-CoV-2 titers
Andy R. Eugene
medRxiv 2020.12.17.20248442; doi: https://doi.org/10.1101/2020.12.17.20248442
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12336)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4179)
- Geriatric Medicine (393)
- Health Economics (689)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (865)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)